Literature DB >> 10487674

Levels of leptin during hydrocortisone infusions that mimic normal and reversed diurnal cortisol levels in subjects with adrenal insufficiency.

J Q Purnell1, M H Samuels.   

Abstract

Levels of leptin throughout the day follow a circadian pattern, with a trough in the late morning/early afternoon and a peak at midnight. This pattern of appearance of leptin correlates inversely with the circadian appearance of cortisol. Pharmacological doses of cortisol increase leptin messenger RNA expression in vitro and raise plasma leptin levels in animals and humans. To determine whether the circadian appearance of leptin might be accounted for by delayed effects from physiological cortisol secretion on fat cells, seven subjects with confirmed adrenal failure were admitted to the Clinical Research Center, on three separate dates, to receive 48-h infusions of: continuous normal saline (NS), a normal daily amount and diurnal pattern of cortisol (ND), and a normal daily amount but reversed diurnal pattern of cortisol. Blood samples were taken every 15 min during the second 24 h of infusion and pooled for hourly measurements of leptin. The circadian pattern of leptin appearance was unchanged during all of the infusion protocols. Area-under-the-curve analysis showed no differences in the total amount of leptin during the NS and ND protocols (20,565 ng/mL x 24 h vs. 20,637 ng/mL x 24 h during NS and ND protocols, respectively; P = 0.94). Acute changes in physiological levels of cortisol do not affect the circadian appearance of leptin in subjects with adrenal failure, nor is cortisol required to maintain normal leptin levels for up to 72 h. The circadian variation of leptin levels cannot be accounted for by normal activity of the hypothalamic-pituitary-adrenal axis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487674     DOI: 10.1210/jcem.84.9.5990

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Regulation of leptin production.

Authors:  R V Considine
Journal:  Rev Endocr Metab Disord       Date:  2001-10       Impact factor: 6.514

2.  Adverse metabolic and cardiovascular consequences of circadian misalignment.

Authors:  Frank A J L Scheer; Michael F Hilton; Christos S Mantzoros; Steven A Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

3.  A pulse of insulin and dexamethasone stimulates serum leptin in fasting human subjects.

Authors:  B Laferrère; A Caixas; S K Fried; C Bashore; J Kim; F X Pi-Sunyer
Journal:  Eur J Endocrinol       Date:  2002-06       Impact factor: 6.664

4.  Growth hormone (GH) secretion in primary adrenal insufficiency: effects of cortisol withdrawal and patterned replacement on GH pulsatility and circadian rhythmicity.

Authors:  A L Barkan; R DeMott-Friberg; M H Samuels
Journal:  Pituitary       Date:  2000-11       Impact factor: 4.107

5.  Effect of small doses of dexamethasone on plasma leptin levels in normal and obese subjects: a dose-response study.

Authors:  P Putignano; A Brunani; A Dubini; M Bertolini; R Pasquali; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

6.  Inhibiting endogenous cortisol blunts the meal-entrained rise in serum leptin.

Authors:  Blandine Laferrère; Cynthia Abraham; Marianne Awad; Stephanie Jean-Baptiste; Allison B Hart; Pilar Garcia-Lorda; Peter Kokkoris; Colleen D Russell
Journal:  J Clin Endocrinol Metab       Date:  2006-03-14       Impact factor: 5.958

7.  Steroid replacement in primary adrenal failure does not appear to affect circulating adipokines.

Authors:  Marta Fichna; Piotr Fichna; Maria Gryczyńska; Agata Czarnywojtek; Magdalena Żurawek; Marek Ruchała
Journal:  Endocrine       Date:  2014-08-17       Impact factor: 3.633

8.  Health impact of fasting in Saudi Arabia during Ramadan: association with disturbed circadian rhythm and metabolic and sleeping patterns.

Authors:  Ghada M Ajabnoor; Suhad Bahijri; Anwar Borai; Altaf A Abdulkhaliq; Jumana Y Al-Aama; George P Chrousos
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.